We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

178 hedge funds and large institutions have $1.96B invested in Rocket Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 74 increasing their positions, 50 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $5.17M | Put options by funds: $3.15M

48% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 50

1.56% less ownership

Funds ownership: 102.06% → 100.51% (-1.6%)

4% less funds holding

Funds holding: 186 → 178 (-8)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

21% less capital invested

Capital invested by funds: $2.48B → $1.96B (-$522M)

22% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 27

Holders
178
Holders Change
-8
Holders Change %
-4.3%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
21
Increased
74
Reduced
50
Closed
27
Calls
$5.17M
Puts
$3.15M
Net Calls
+$2.02M
Net Calls Change
-$15.1M

Top Buyers

1
WP
Woodline Partners
California
+$12.9M
2
EC
EcoR1 Capital
California
+$11.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$10.1M
4
Citadel Advisors
Citadel Advisors
Florida
+$8M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$7.9M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$34M
2
State Street
State Street
Massachusetts
-$32.5M
3
LGM
Logos Global Management
California
-$21.8M
4
PA
Perceptive Advisors
New York
-$12.7M
5
CAM
Cormorant Asset Management
Massachusetts
-$8.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
101
Wells Fargo
California
$533K +$43.8K +1,907 +8%
Principal Financial Group
102
Principal Financial Group
Iowa
$532K -$139K -6,072 -20%
Los Angeles Capital Management
103
Los Angeles Capital Management
California
$528K – – –
HighTower Advisors
104
HighTower Advisors
Illinois
$525K +$3.79K +165 +0.7%
Two Sigma Investments
105
Two Sigma Investments
New York
$497K -$2.91M -126,917 -85%
PA
106
Profund Advisors
Maryland
$478K -$665K -28,947 -57%
VOYA Investment Management
107
VOYA Investment Management
Georgia
$470K +$27.4K +1,191 +6%
VIM
108
VELA Investment Management
Ohio
$447K – – –
Stifel Financial
109
Stifel Financial
Missouri
$443K +$12.3K +537 +3%
BG
110
Bellevue Group
Switzerland
$424K – – –
Marshall Wace
111
Marshall Wace
United Kingdom
$422K +$450K +19,583 New
YC
112
Yarbrough Capital
Tennessee
$421K – – –
Handelsbanken Fonder
113
Handelsbanken Fonder
Sweden
$392K +$13.8K +600 +3%
CCIA
114
Campbell & Co Investment Adviser
Maryland
$387K +$413K +17,992 New
ASRS
115
Arizona State Retirement System
Arizona
$382K +$8.98K +391 +2%
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$368K +$91.8K +3,995 +31%
State Board of Administration of Florida Retirement System
117
State Board of Administration of Florida Retirement System
Florida
$351K -$4.36K -190 -1%
AWM
118
Avior Wealth Management
Nebraska
$345K +$28.9K +1,259 +9%
PNC Financial Services Group
119
PNC Financial Services Group
Pennsylvania
$334K +$17.6K +768 +5%
Cetera Investment Advisers
120
Cetera Investment Advisers
Illinois
$320K +$49.1K +2,139 +17%
TRCT
121
Tower Research Capital (TRC)
New York
$314K +$312K +13,591 +1,340%
ProShare Advisors
122
ProShare Advisors
Maryland
$302K -$82.8K -3,604 -20%
Teacher Retirement System of Texas
123
Teacher Retirement System of Texas
Texas
$300K -$3.03K -132 -0.9%
DIA
124
Dana Investment Advisors
Wisconsin
$298K +$13.5K +586 +4%
Mitsubishi UFJ Asset Management
125
Mitsubishi UFJ Asset Management
Japan
$282K +$50.9K +2,217 +20%
3 4
5
6 7

RCKT Hedge Fund Activity: Q2 2024 in Review

178 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q2 2024, worth a combined $1.96B — down 21% from $2.48B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of RCKT and 21 opened new positions — a net loss of 6 holders — while 50 trimmed existing stakes and 74 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $12.9M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $34M sold.

  • 178 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q2 2024, down from 186 in Q1 2024.
  • Funds reported $1.96B of Rocket Pharmaceuticals stock for Q2 2024, down 21% quarter-over-quarter.
  • 21 funds opened new Rocket Pharmaceuticals positions in Q2 2024 and 27 closed out, a net change of -6 holders.
  • The largest Rocket Pharmaceuticals buyer in Q2 2024 was Woodline Partners, an estimated $12.9M added.
  • The largest Rocket Pharmaceuticals seller in Q2 2024 was Avoro Capital Advisors, an estimated $34M sold.

Based on aggregated 13F filings for Q2 2024.